Online Program Home
My Program

Abstract Details

Activity Number: 32 - Statistical Methods in Dose-Finding Studies
Type: Contributed
Date/Time: Sunday, July 28, 2019 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #305011 Presentation
Title: Bayesian Method Based Dose Escalation in Clinical Trials with Combination Therapy
Author(s): Shanmei Liao* and Theis Lange
Companies: BeiGene and University of Copenhagen, section of biostatistics
Keywords: Dose escalation; Bayesian analysis; Oncology research

With increasing competition in oncology drug development and emerging of new entities allowing more combination therapies, research demand for efficient and precise methods in identifying the most tolerable doses reaches historical high. While the problem is an order of magnitude harder since there is a whole frontier of dose combinations acceptable from safety perspective instead of one single dose in monotherapy dose escalation. We propose a two-stage, Bayesian method based, split cohort design (TBSC design), where an initial rule based escalation (i.e. 3+3-like along the diagonal of dose combination) is followed by an adaptive stage where a continuously updated Bayesian logistic regression is used to suggest the dose combinations on the location of the acceptable-risk-frontier.In addition, our proposed method can incorporate a) concurrently running mono-trials, b) insert new doses if deemed required, c) incorporate historical information in case one of the entity is well-known and d) initiate several dose cohorts in parallel to speed up trial completion. The proposed method is compared to others used in industry in terms of precision and trial speed.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2019 program